The Chopra Foundation Announces Partnership with Cybin Inc. to Increase Education and Awareness of the Potential Use of Psychedelics in Supporting Well-Being and Mental Health
February 15 2022 - 8:29AM
InvestorsHub NewsWire
- Cybin's holistic and innovative approach to developing
improved treatment options for patients aligns with the goals of
the Foundation's NeverAlone Initiative -
- Fireside chat featuring Deepak Chopra, M.D., FACP, The
Chopra Foundation Founder, and Doug Drysdale, Cybin's Chief
Executive Officer, scheduled for Wednesday, February 23, 2022 at
12:00 p.m. ET -
SAN DIEGO, CA -- February 15, 2022 -- InvestorsHub NewsWire
-- The Chopra Foundation (the "Foundation"), a
not-for-profit organization founded by Dr. Deepak Chopra,
dedicated to improving health and well-being, today announced a
partnership with Cybin Inc. (NEO:CYBN)
(NYSE
AMERICAN:CYBN) ("Cybin"), a biopharmaceutical company
focused on progressing "Psychedelics to Therapeutics™". The
Foundation is working closely with Cybin to support education and
awareness about its groundbreaking research to harness the
potential of psychedelic therapies in mental health. Emerging
research shows that psychedelic-assisted therapy can potentially
improve the quality of life for people suffering with mental
illnesses, including those specific indications that Cybin is
targeting, such as Major Depressive Disorder, Alcohol Use Disorder
and Anxiety Disorders.
"The need for new and more effective treatments across the
mental health spectrum is more urgent today than ever. Through our
NeverAlone movement, we aim to combine forces with the best and
brightest across businesses, policymakers, mental health
professionals, and others – all with the goal of building
awareness, advancing scientific research, and creating a global
community to ensure widespread access to well-being resources. As
the number of companies pursuing psychedelic-based therapies
continues to grow, the Foundation is particularly excited about
partnering with Cybin based on its commitment to global well-being
and mental health," said Dr. Deepak Chopra, The Chopra
Foundation Founder, Chairman of the Board and Director.
The Chopra Foundation is dedicated to improving the world's
well-being, cultivating spiritual knowledge, expanding
consciousness, and promoting world peace to all members of the
human family. The Foundation's NeverAlone Initiative is focused on
reframing the conversation around mental health by forging an
alliance of people and organizations dedicated to lighting the path
for the world to proactively pursue joy, the ultimate measure of
well-being.
"Cybin has cultivated a leadership position in this space based
on their proprietary scientific approach that delivers the healing
properties of classic psychedelics while reducing variable side
effects that have prevented these natural compounds from becoming
therapies in the past. This differentiated method is thoughtful and
ethical and Cybin is one of the only companies that may truly
address the needs of patients and providers. Their vision for
improving the landscape of mental illness perfectly aligns with our
goals and we look forward to a productive partnership to further
both of our missions," concluded Dr. Chopra.
Cybin's team of talented industry experts and scientists are
working to bring revolutionary psychedelic-based treatment options
to patients in need. Cybin's core values center on its holistic
approach to therapeutics and its commitment to transforming the
standard of care in mental health.
In addition to its ongoing preclinical, clinical and
investigative drug development programs, Cybin shares the
Foundation's commitment to ensuring access to well-being resources
for all, including those in underserved communities.
"We are honored to partner with The Chopra Foundation, and
specifically, to be part of the NeverAlone Initiative. Much is
understood about psychedelics, as they have been studied in
academia for decades, but there is still much investigative work to
be done. At Cybin, we are using medicinal chemistry and drug
delivery technologies to build on existing clinical data and
improve the patient experience by overcoming the limitations of
current treatments for mental illness. We share the Foundation's
pioneering spirit with regard to mental health and well-being and
its goal of ensuring accessibility to much-needed treatment options
to those in need," said Doug Drysdale, Cybin's Chief Executive
Officer.
The Chopra Foundation and Cybin plan to host a fireside chat
featuring Dr. Chopra and Mr. Drysdale to discuss the current status
and future of psychedelics as therapeutics on Wednesday,
February 23, 2022 at 12:00 p.m. ET. To register for
online access to the fireside chat, please click
here.
About The Chopra Foundation and Never Alone
The Chopra Foundation is a 501 (c) (3) organization (#36-4793898)
dedicated to improving health and well-being, cultivating spiritual
knowledge, expanding consciousness, and promoting world peace to
all members of the human family. The Foundation's Never Alone
movement will be providing the world with the tools to proactively
pursue their path to joy and freedom from suffering.
Cybin (NEO:CYBN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Cybin (NEO:CYBN)
Historical Stock Chart
From Apr 2023 to Apr 2024
